Balyasny Asset Management’s HCA Healthcare HCA Stock Holding History

Balyasny Asset Management’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.56M	Buy	+11,700	New	+$4.95M	0.01%	1409
2025 Q1	–	Sell	-320,000	Closed	-$96M	–	2989
2024 Q4	$96M	Buy	320,000 +317,600	+13,233%	+$111M	0.14%	162
2024 Q3	$975K	Buy	+2,400	New	+$879K	﹤0.01%	1977
2020 Q4	–	Sell	-60,000	Closed	-$7.48M	–	1485
2020 Q3	$7.48M	Buy	+60,000	New	+$7.43M	0.05%	476
2016 Q2	–	Sell	-250,000	Closed	-$19.5M	–	1277
2016 Q1	$19.5M	Buy	+250,000	New	+$17.5M	0.12%	257
2013 Q3	–	Sell	-643,600	Closed	-$23.2M	–	624
2013 Q2	$23.2M	Buy	+643,600	New	+$24.9M	0.39%	50

Other funds holding HCA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Balyasny Asset Management's HCA Position: Q2 2026 in Review

Balyasny Asset Management increased its HCA Healthcare (HCA) stake by 40% in Q2 2026, buying an estimated $429K and bringing the position to 3,523 shares worth $1.37M. The position accounts for ﹤0.01% of the portfolio, ranked #2029.

Balyasny Asset Management first reported a position in HCA in Q2 2013 and has held it in 42 quarters since. The position peaked at $63.9M in Q4 2023. 1,342 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

Balyasny Asset Management held 3,523 shares of HCA Healthcare worth $1.37M as of Q2 2026.
Balyasny Asset Management bought 1,015 HCA Healthcare shares in Q2 2026, an estimated $429K.
HCA Healthcare made up ﹤0.01% of Balyasny Asset Management's portfolio in Q2 2026, its #2029 holding.
Balyasny Asset Management first reported a position in HCA Healthcare in Q2 2013 and has held it in 42 quarters since.
Balyasny Asset Management's HCA Healthcare position peaked at $63.9M in Q4 2023.
1,342 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.